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Aurora-A and an Interacting Activator,
the LIM Protein Ajuba, Are Required
for Mitotic Commitment in Human Cells
cyclin B1-Cdk1 complex appears first at the centro-
some, suggesting that this organelle, as it matures, may
facilitate the activation of mitotic regulators required for
the commitment of cells into mitosis (Jackman et al.,
2003; Hannak et al., 2001). The signaling pathways that
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initiate centrosome maturation are thus considered toGraduate School of Medical Sciences
be activated during late G2 phase before this eventKumamoto University
becomes morphologically discernible at M phase, but1-1-1 Honjo
those signals remain largely unknown, however (PinesKumamoto, 860-8556
and Rieder, 2001).Japan
Genetic studies in yeast and flies have identified sev-2 Department of Surgery
eral kinases, collectively known as mitotic kinases, thatGraduate School of Medical and Dental Sciences
are associated with the mitotic machinery and whoseNiigata University
activities peak during late G2 to M phases. Like Cdk1,1-757 Asahimachi-dori
these mitotic kinases are also thought to play importantNiigata, 951-8510
and specific roles in both morphological and biochemi-Japan
cal mitotic transitions (Nigg, 2001). These enzymes in-
clude Polo kinase, NIMA-related kinase, WARTS-related
kinases, and Aurora kinases, and their structures andSummary
functions have been conserved, with slight deviations,
through evolution. It remains to be determined, however,Aurora family kinases contribute to regulation of mito-
how and where these mitotic kinases are activated insis. Using RNA interference in synchronized HeLa
the cell as well as how their activation is coordinatedcells, we now show that Aurora-A is required for mitotic
with that of Cdk1 (Nigg, 2001).entry. We found that initial activation of Aurora-A in late
The Aurora family comprises a large number of ki-G2 phase of the cell cycle is essential for recruitment
nases whose structure and function are evolutionarilyof the cyclin B1-Cdk1 complex to centrosomes, where
conserved. Whereas budding yeast contains only oneit becomes activated and commits cells to mitosis. A
Aurora kinase, termed Ipl1, metazoans contain at leasttwo-hybrid screen identified the LIM protein Ajuba as
two subfamilies of these enzymes, designated Aurora-Aan Aurora-A binding protein. Ajuba and Aurora-A inter-
and Aurora-B, that appear to play distinct roles. In mam-act in mitotic cells and become phosphorylated as they
malian cells, the contributions of Aurora-B to chromo-do so. In vitro analyses revealed that Ajuba induces
some alignment and cytokinesis are relatively well char-the autophosphorylation and consequent activation of
acterized. Aurora-B localizes to condensing chromatinAurora-A. Depletion of Ajuba prevented activation of
and then gradually accumulates at the centromere byAurora-A at centrosomes in late G2 phase and inhib-
prometaphase in order to control kinetochore-microtu-ited mitotic entry. Overall, our data suggest that Ajuba
bule connections (Hauf et al., 2003; Ditchfield et al.,is an essential activator of Aurora-A in mitotic com-
2003). In anaphase, Aurora-B moves to the central spin-
mitment.
dle or midbody to regulate cytokinesis (Terada, 2001;
Adams et al., 2001). The activity of Aurora-B is regulated
Introduction through its association with the inner centromere protein
(INCENP) in a manner similar to that by which the activity
Mitosis is conventionally divided into five phases— of Ipl1 is regulated by its association with Sli15, the
prophase, prometaphase, metaphase, anaphase, and budding yeast ortholog of INCENP (Kim et al., 1999;
telophase—on the basis of changes in the structure and Adams et al., 2001).
behavior of the spindle and chromosomes. Prophase is In contrast, relatively little is known about Aurora-A.
characterized by the apparent onset and progression Although phenotypic analyses of hypomorphic mutants
of chromosome condensation in the nucleus and by or of the effects of RNA interference (RNAi) in various
centrosome enlargement and an increase in microtubule organisms and cell types have yielded slightly different
nucleation activity, referred to as centrosome matura- results, Aurora-A has been implicated in regulation of
tion, in the cytoplasm. the centrosome and mitotic microtubules. Mutations in
Centrosome maturation is associated with the recruit- the Aurora-A gene of Drosophila melanogaster have
ment of multiple proteins, including not only -tubulin been associated with centrosomal abnormalities, in-
and pericentriolar components required for microtubule cluding a characteristic monopolar organization (Glover
nucleation, but also cell cycle regulators such as cyclin et al., 1995). A weak hypomorphic Aurora-A mutation in
B1, cyclin-dependent kinase 1 (Cdk1), and Polo-like ki- this organism resulted in short astral microtubules (Giet
nase 1 (Plk1) (Bailly et al., 1989; Nigg, 2001). The active et al., 2002). The Aurora-A protein Eg2 in Xenopus di-
rectly associates with microtubules, and its kinase activ-
ity is essential for bipolar spindle assembly in vitro*Correspondence: hsaya@gpo.kumamoto-u.ac.jp
(Roghi et al., 1998). Analysis of Aurora-A function in3 Present address: Research Institute of Molecular Pathology (IMP),
Dr. Bohrgasse 7, A-1030, Vienna, Austria. Caenorhabditis elegans embryos by RNAi revealed an
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important role for this protein in centrosome maturation (Figure 1A). In contrast, immunofluorescence analysis
revealed that activated Aurora-A was present at centro-(Hannak et al., 2001): Aurora-A does not contribute to
centrosome separation before nuclear envelope break- somes in more than 40% of cells at 8.5 hr after the
release, and a substantial population (20%) of cellsdown (NEBD) but, rather, is important for maintenance
of centrosome separation. The molecular pathways by was already positive for active Aurora-A 1 hr earlier,
when most cells were still in G2 phase (Figure 1C). Towhich Aurora-A controls the mitotic machinery and by
which it is itself regulated remain largely unknown, determine more precisely when Aurora-A is first acti-
vated, we stained cells with both T288P and antibodieshowever.
We now provide molecular insight into the regulation specific for histone H3 phosphorylated on Ser10, a
marker of M phase. Phosphorylation of Aurora-A wasof mitotic entry in human cells. With the use of antibodies
specific for the active form of Aurora-A, we found that apparent before that of histone H3 (Figure 1D), demon-
strating that Aurora-A is first activated during G2 phase.Aurora-A is first activated in late G2 phase at the centro-
some of HeLa cells. Application of RNAi to synchronized These observations reveal that active Aurora-A initially
appears at centrosomes during late G2 phase and thatHeLa cells revealed that this activation of Aurora-A is
required for the initial activation of cyclin B1-Cdk1 at this event precedes the robust activation detected bio-
chemically during early mitosis.the centrosome and, therefore, for entry into mitosis. A
two-hybrid screen identified Ajuba as a protein that
binds to Aurora-A, and this interaction was shown to Aurora-A Kinase Is Essential
result in the autophosphorylation and consequent acti- for G2-M Progression
vation of Aurora-A. The autophosphorylation of Aurora- To investigate the importance of human Aurora kinases
A facilitated by interaction with Ajuba underlies the acti- in G2-M transition, we combined cell synchronization
vation of Aurora-A at the centrosome that is required with RNAi. HeLa cells were transfected with small in-
for the commitment of cells to mitosis. terfering RNAs (siRNAs) in the interval between the two
thymidine-blocks and were examined for expression of
Aurora-A and Aurora-B between 6–9 hr after releaseResults
into the cell cycle (Figure 2A). Transfection of cells with
siRNAs specific for Aurora-A or Aurora-B resulted inTemporal and Spatial Control
of Aurora-A Activation specific reduction in levels of the corresponding protein
(Figure 2B). Depletion of Aurora-A markedly impairedTo study the temporal regulation of Aurora-A activation,
we synchronized HeLa cells at the G1-S boundary by the ability of cells to enter mitosis, whereas transfection
of cells with the siRNA specific for Aurora-B or with athe double thymidine-block protocol and then moni-
tored the abundance and kinase activity of the protein control siRNA had no such effect (Figures 2C and 2D).
Similar results were obtained with U2OS human osteo-through mitosis. Consistent with previous observations
(Marumoto et al., 2002), the amounts of both Aurora-A sarcoma cells (data not shown).
To characterize the impairment in mitotic entry inprotein and kinase activity increased during late G2 to
M phase, beginning 8.5 hr after release of the block Aurora-A-deficient cells, we examined cell cycle pro-
gression by flow cytometry. Monitoring of DNA content(Figure 1A). Given that phosphorylation of Aurora-A on
Thr288, which is located in the activation T loop of the revealed that the kinetics of DNA replication (S phase
progression) was not affected by Aurora-A depletionkinase, results in a marked increase in enzymatic activity
(Walter et al., 2000), we examined the phosphorylation (see Supplemental Figure S1A online at http://www.
cell.com/cgi/content/full/114/5/585/DC1). Rather, thestate of Thr288 by immunoblot analysis with antibodies
(T288P) specific for Aurora-A phosphorylated on this Aurora-A-deficient cells appeared to be delayed in G2
phase, as indicated by the marked cytoplasmic accumu-residue. The phosphorylation of Aurora-A on Thr288 oc-
curred during G2-M phases, coincident with the enzy- lation of cyclin B1 (Figure 2E). This G2 delay induced
by Aurora-A depletion was not clearly overridden bymatic activation (Figure 1A). The phosphorylation of
Thr288 thus provides an index of the enzymatic activa- treatment of the cells with caffeine (Supplemental Figure
S1B), which inhibits the checkpoint pathway activatedtion of Aurora-A.
We next examined the subcellular distribution of acti- by DNA damage. Moreover, there were no obvious dif-
ferences in the synthesis of mitotic cyclins betweenvated Aurora-A by immunofluorescence analysis with
the T288P antibodies (Figure 1B). The activation of a Aurora-A-deficient cells and those transfected with the
control siRNA (Supplemental Figure S1C), excluding thesmall proportion of Aurora-A was first evident at centro-
somes before chromatin condensation (Figure 1Bb). Ac- possibility that the G2 delay was due to inhibition of
protein synthesis triggered by double-stranded RNA.tivated Aurora-A was subsequently detected in the nu-
cleus, coincident with visible chromatin condensation, Consistent with the delayed mitotic entry, Aurora-A-
depleted cells lacked substantial cyclin B1-associatedat prophase. Finally, increased amounts of activated
Aurora-A were observed at the spindle poles, after kinase activity toward histone H1 in vitro, despite the
marked accumulation of cyclin B1 (Figure 2F). This lackNEBD, at prometaphase.
To clarify the temporal relation between the enzymatic of kinase activity was associated with the phosphoryla-
tion of Cdk1 on Tyr15 (Supplemental Figure S1D). To-activation and subcellular localization of Aurora-A, we
categorized the pattern of T288P staining of synchro- gether, these observations indicate that Aurora-A, but
not Aurora-B, is essential for mitotic entry in culturednized cells during cell cycle progression as exemplified
by the six panels, a–f, in Figure 1B. Activation of Aurora-A human cells.
We also observed that centrosomes remained imma-was first detected 8.5 hr after release from G1-S arrest
by both immunoblot analysis and in vitro kinase assay ture in the Aurora-A-depleted cells, whereas those in
Roles of Aurora-A and Ajuba in Mitotic Entry
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Figure 1. Initial Activation of Aurora-A in Late G2 Phase
(A) Regulation of Aurora-A during the cell cycle. Synchronized HeLa cells were released from the G1-S boundary and, 5.5 hr after release,
nocodazole was added to the medium at a final concentration of 50 ng/ml. At the indicated times after release, whole-cell extracts (WCE)
were subjected to immunoblot analysis (IB) with antibodies to Aurora-A (top) or with T288P (second panel). Equal amounts of cell extracts
were also subjected to immunoprecipitation (IP) with antibodies to Aurora-A, and the resulting precipitates were subjected either to immunoblot
analysis with the same antibodies (third panel) or to an in vitro kinase assay with [-32P]ATP and histone H3 as exogenous substrate (bottom
panel).
(B) Distribution of activated Aurora-A during the cell cycle. HeLa cells treated as in (A) were subjected to indirect immunofluorescence staining
with the T288P antibodies (FITC, green) and antibodies to lamins A and C (Cy5, blue). DNA was visualized by staining with propidium iodide
(red). Cells were staged on the basis of the distribution of activated Aurora-A as indicated: cells negative for T288P staining (a), cells in late
G2 with T288P staining at centrosomes (b), cells in early prophase with staining at centrosomes and weak nuclear staining (c), cells in late
prophase with staining at centrosomes and robust nuclear staining (d), cells at the time of NEBD (e), and cells in prometaphase with staining
at the spindle poles (f).
(C) Spatiotemporal analysis of Aurora-A activation during G2-M phases. At the indicated times after release from G1-S block, 200 cells were
counted and classified according to the pattern of T288P staining as described in (B).
(D) Initial appearance of active Aurora-A at centrosomes during late G2 phase. At 8.5 hr after release from G1-S block, HeLa cells were
subjected to immunofluorescence staining with T288P (FITC, green) and antibodies specific for histone H3 phosphorylated on Ser10 (Texas
red, red). DNA was visualized with Toto3 iodide (blue). Arrowheads indicate cells with active Aurora-A at centrosomes without phosphorylation
of histone H3.
control cells recruited -tubulin and nucleated mitotic tween the initial activation of Aurora-A and that of the
cyclin B1-Cdk1 complex, which is a key initiator of mito-microtubules (Figure 2E). Aurora-A thus appears to con-
tribute to the regulation of centrosome maturation in sis. Like Aurora-A, the active cyclin B1-Cdk1 complex
appears at centrosomes before the substantial activa-human cells, consistent with its function in C. elegans
and D. melanogaster, and raises the possibility that cen- tion characteristic of cell cycle progression through mi-
tosis (Jackman et al., 2003). We therefore examinedtrosome maturation mediated by Aurora-A might play a
role in mitotic entry. whether cyclin B1 is recruited to centrosomes in cells
depleted of Aurora-A. Immunofluorescence analysis of
cells transfected with the control siRNA revealed thatAurora-A Is Required for Initial Activation of Cyclin
B1-Cdk1 at Centrosomes the number of cells in which cyclin B1 was localized to
centrosomes increased between 7.5–9 hr after releaseTo study further the nature of the G2 delay associated
with Aurora-A deficiency, we examined the relation be- from G1-S arrest (Figures 3A and 3B). In contrast, such
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Figure 2. Aurora-A Is Essential for Mitotic Entry in HeLa Cells
(A) Experimental protocol for cell cycle synchronization by double thymidine-block and for transfection with siRNA.
(B) Inhibition of Aurora-A and Aurora-B expression by transfection of cells with siRNAs. HeLa cells were subjected to the protocol shown in
(A) with control, Aurora-A, or Aurora-B siRNAs. At the indicated times, whole-cell extracts were subjected to immunoblot analysis with
antibodies to the indicated proteins.
(C) Phase-contrast images of cells transfected with control (a), Aurora-A (b), or Aurora-B (c) siRNAs. Cells were observed 9 hr after release.
Scale bar, 200 m.
(D) Time course of the mitotic index of cells transfected with control, Aurora-A155 (nucleotides 155–173), Aurora-A725 (nucleotides 725–743), or
Aurora-B siRNAs. Cells were fixed and stained with DAPI at the indicated times, and the number of mitotic cells out of a total of 500 cells
examined was determined.
(E) Distribution of cyclin B1 and tubulin in Aurora-A-depleted cells. Cells transfected with control (a and c) or Aurora-A (b and d) siRNAs were
subjected to immunofluorescence analysis 9 hr after release. The distribution of cyclin B1 was revealed by FITC fluorescence (a and b), and
those of -tubulin and -tubulin were revealed by FITC and Texas red, respectively (c and d). Arrowheads indicate -tubulin-containing
centrosomes. Scale bar, 20 m.
(F) Lack of cyclin B1-associated kinase activity in Aurora-A-deficient cells. At the indicated times after release, cells transfected with control
or Aurora-A siRNAs were subjected to immunoprecipitation with antibodies to cyclin B1, and the resulting precipitates were both assayed
for kinase activity with histone H1 as substrate and subjected to immunoblot analysis with antibodies to cyclin B1.
an effect was not observed in Aurora-A-deficient cells. by transfection with a cyclin B1 siRNA (Figures 3C and
3D). Although the entry of cells into mitosis was greatlyThese results suggest that Aurora-A is required for the
initial recruitment of cyclin B1-Cdk1 at the centrosome, inhibited by each of these treatments (data not shown),
the percentage of cells showing Aurora-A activation atan event that correlates with centrosome maturation.
Cells lacking Cdk1 activity were also analyzed for ini- centrosomes was largely unaffected (Figure 3D). How-
ever, the intensity of the T288P signal at centrosomestial Aurora-A activation at the centrosome. Activation of
Cdk1 was inhibited either by exposure of G2 cells to of cells transfected with cyclin B1 siRNA was weaker
than that apparent in control cells, and the cyclin B1-the potent Cdk1-specific inhibitor butyrolactone I (at a
concentration [50 M] that does not inhibit the kinase depleted cells did not manifest the pronounced nuclear
activation of Aurora-A as observed in control cells (Fig-activity of Aurora-A in vitro [Marumoto et al., 2002]) or
Roles of Aurora-A and Ajuba in Mitotic Entry
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Figure 3. Relation between the Activation of Aurora-A and that of Cyclin B1-Cdk1 at the Centrosome
(A) Localization of cyclin B1 in Aurora-A-depleted cells. HeLa cells transfected with control (a and b) or Aurora-A (c and d) siRNAs were
subjected to immunofluorescence analysis 9 hr after release from G1-S arrest. Aurora-A and cyclin B1 were revealed by Rhodamine (a and
c) and FITC (b and d) fluorescence, respectively. Arrowheads indicate cyclin B1-positive centrosomes. Scale bar, 20 m.
(B) Role of Aurora-A in recruitment of cyclin B1 to the centrosome. At the indicated times after release from G1-S arrest,100 cells transfected
with control or Aurora-A siRNAs were scored by immunofluorescence analysis for the presence of cyclin B1 at centrosomes, which were
detected with antibodies to pericentrin.
(C) Localization of active Aurora-A in cyclin B1-depleted cells. HeLa cells transfected with control (a and b) or cyclin B1 (c and d) siRNAs
were subjected to immunofluorescence analysis 9 hr after release from G1-S arrest. The distribution of cyclin B1 was revealed by rhodamine
(a and c) and that of T288P immunoreactivity by FITC (b and d). Arrowheads indicate T288P-positive centrosomes. Scale bar, 20 m.
(D) Centrosomal localization of active Aurora-A independent of Cdk1 activity. At the indicated times after release from G1-S arrest, 100
HeLa cells that had been transfected with cyclin B1 siRNA or treated with butyrolactone I were scored for centrosomal staining with T288P;
centrosomes were detected by staining with antibodies to -tubulin. Control cells were either transfected with control siRNA (open bars) or
not treated with the Cdk1 inhibitor (solid bars), as appropriate. Butyrolactone I was added to the medium 7 hr after release to a final
concentration of 50 M.
ure 3C). These observations indicate that the activation a HeLa cDNA library. From a total of 2.4  107 trans-
formants, 135 positive clones were obtained. Theseof both Aurora-A and Cdk1 at centrosomes constitutes
an essential early event in the progression of cells to- clones were then subjected to secondary screening to
eliminate false positives. Nucleotide sequencing re-ward mitosis, and they suggested the existence of a
mechanism for Aurora-A activation that is independent vealed that five of the ten confirmed positive clones
contained an open reading frame, including a stop co-of cyclin B1-Cdk1.
don, that encoded a protein with substantial homology
to murine Ajuba (Figure 4A), a LIM domain-containingIdentification of Ajuba As an Aurora-A
Binding Protein protein that has been suggested to promote meiotic
maturation of Xenopus oocytes (Goyal et al., 1999). Iso-To obtain molecular insight into Aurora-A function and
its regulation at the G2-M transition, we performed a lation of a full-length cDNA for this human homolog
of Ajuba from a HeLa cDNA library revealed that theyeast two-hybrid screen to identify proteins that interact
with Aurora-A. The region of human Aurora-A compris- predicted protein shares 92.9% amino acid identity with
mouse Ajuba.ing amino acids 1–129 was used as the bait to screen
Cell
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Figure 4. Identification of Ajuba As an Aurora-A Binding Protein
(A) Domain organization of human Aurora-A and human Ajuba. The hatched bar below the Aurora-A structure represents the portion of the
protein used as the bait for two-hybrid screening. The solid bar below the Ajuba structure indicates the portion encoded by the positive
clones recovered in the screen. NES, nuclear export sequence. Polyclonal antibodies to human Ajuba were generated in rabbits and mice by
injecting recombinant proteins corresponding to the indicated sequences.
(B) Interaction of ectopically expressed Ajuba and Aurora-A in COS-7 cells. Lysates of cells expressing Flag-tagged Aurora-A, HA-tagged
Ajuba, or both proteins were subjected to immunoblot analysis with antibodies to Flag or to HA as indicated (lanes 1–4). The same cell lysates
were also subjected to immunoprecipitation with antibodies to HA (lanes 5–8) or to Flag (lanes 9–12), and the resulting precipitates were
subjected to immunoblot analysis with antibodies to Flag or to HA.
(C) Detection of endogenous Ajuba. Lysates of exponentially growing HeLa cells were subjected to immunoprecipitation with either preimmune
rabbit serum (lane 1) or rabbit antiserum to human Ajuba (lane 2), and the resulting precipitates were subjected to immunoblot analysis with
mouse antibodies to Ajuba. Arrow indicates Ajuba, and asterisk indicates rabbit immunoglobulin.
(D) Comparison of the electrophoretic mobility of Ajuba between interphase and mitotic cells. Lysates of interphase or mitotic HeLa cells
were subjected to immunoprecipitation and immunoblot analysis as in (C).
(E) Phosphorylation of Ajuba during mitosis. Ajuba immunoprecipitates prepared from mitotic HeLa cells were incubated for 30 min at 37C
with or without 50 U of calf intestinal alkaline phosphatase (CIAP) (200 U/ml) or 50 mM -glycerophosphate, as indicated. The precipitates
were then subjected to immunoblot analysis with antibodies to Ajuba.
(F) Subcellular localization of endogenous Ajuba. Synchronized HeLa cells were subjected to immunofluorescence staining with purified rabbit
antibodies to Ajuba and FITC-labeled secondary antibodies (top). Cells were also stained with propidium iodide (red) and the signal was
merged with that for FITC (bottom). Representative cells in G2-M phase are shown in chronological order (a–e). Note that Ajuba appears on
centrosomes that are located next to each other (b, arrowheads). Scale bar, 20 m.
To examine whether Ajuba interacts with Aurora-A 4A). Because of its low abundance in HeLa cells, it was
barely possible to detect Ajuba directly by immunoblotin mammalian cells, we transfected COS-7 cells with
expression vectors for the full-length proteins tagged analysis of whole-cell extracts. We therefore immuno-
precipitated Ajuba with the rabbit antibodies and sub-at their NH2 termini with the hemagglutinin (HA) and Flag
epitopes, respectively. Lysates of cells expressing both jected the resulting precipitates to immunoblot analysis
with the mouse antibodies. Endogenous Ajuba was de-HA-Ajuba and Flag-Aurora-A were then subjected to
immunoprecipitation with antibodies to Flag. Immu- tected as a broad band corresponding to a molecular
size of 55–60 kDa (Figure 4C), consistent with the calcu-noblot analysis of the resulting precipitates revealed the
presence of HA-Ajuba (Figure 4B). Conversely, Flag- lated molecular mass of 56.9 kDa. Furthermore, Ajuba
derived from mitotic cells exhibited a lower electropho-Aurora-A was detected in immunoprecipitates prepared
with antibodies to HA. These results thus indicate that retic mobility than did that from interphase cells (Figure
4D). This lower-mobility form of Ajuba was convertedAjuba and Aurora-A interact in mammalian cells.
To characterize human Ajuba, we prepared mouse to the higher-mobility form by phosphatase treatment
in a manner that was sensitive to -glycerophosphateand rabbit polyclonal antibodies to the protein (Figure
Roles of Aurora-A and Ajuba in Mitotic Entry
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(Figure 4E), indicating that the lower-mobility form corre- side in the pre-LIM domain, but not in the LIM domain
(Supplemental Figure S2A). These observations thussponded to phosphorylated Ajuba. Ajuba thus under-
goes phosphorylation during mitosis. raised the possibility that Ajuba might be a target of the
kinase activity of Aurora-A.We examined the subcellular distribution of Ajuba in
HeLa cells by immunofluorescence analysis with the We next examined whether the kinase activity of
Aurora-A affects the interaction between the two pro-purified rabbit antibodies to human Ajuba. Consistent
with previous observations with mouse Ajuba (Goyal teins. COS-7 cells were transfected with expression vec-
tors for both HA-Ajuba and either Flag-tagged wild-typeet al., 1999), faint staining of endogenous Ajuba was
apparent in the cytoplasm. We noticed, however, that Aurora-A or kinase-inactive mutants thereof (K162M and
T288A, in which Thr288 and Thr287 are both replacedAjuba is localized to the centrosome in a fraction of
cells, and those cells with centrosome staining in- with alanines to prevent T loop activation). Immunopre-
cipitation followed by immunoblot analysis revealed thecreased when cells were synchronized at G2-M. Closer
observation showed that Ajuba first appears at the cen- presence of HA-Ajuba in the precipitates prepared from
cells expressing wild-type Aurora-A, but not in thosetrosome earlier than obvious chromosome condensa-
tion and becomes stronger as cells proceed through prepared from cells expressing either of the kinase-inac-
tive mutants (Figure 5E). Furthermore, phosphorylatedmitosis (Figure 4F). This centrosomal staining was not
apparent in cells transfected with Ajuba siRNA (data not Ajuba, which appeared as a lower-mobility band in cells
coexpressing wild-type Aurora-A, was specifically co-shown), eliminating the possibility that it was due to a
nonspecific reaction of the antibodies. The observation precipitated with Aurora-A.
We also noticed that a lower-mobility form of Aurora-Athat Ajuba concentrates on centrosome during G2-M
phase suggests that the interaction with Aurora-A could appeared in cells expressing both wild-type Aurora-A
and Ajuba, suggesting that both proteins are phosphory-take place in this specific phase and place.
lated during complex formation. To examine this possi-
bility further in vivo, we subjected immunoprecipitatesDelineation of the Ajuba Domain Responsible
of endogenous Ajuba prepared from mitotic HeLa cellsfor Interaction with Aurora-A
to immunoblot analysis with antibodies to Aurora-A. Al-To delineate the region of Ajuba responsible for its asso-
though both the phosphorylated and nonphosphory-ciation with Aurora-A, we generated various deletion
lated forms of endogenous Aurora-A were detected inmutants of Ajuba fused with glutathione S-transferase
the input lysate, the phosphorylated form was specifi-(GST) (Figure 5A). GST-Ajuba fusion proteins were incu-
cally coprecipitated with Ajuba (Figure 5F). These databated with a purified hexahistidine (His6)-tagged frag-
thus demonstrate that Aurora-A interacts with Ajubament of Aurora-A (amino acids 1–129), the same frag-
during mitosis and that both proteins are phosphory-ment that was used as the bait in the two-hybrid screen,
lated as they form a complex.and were then precipitated with glutathione-Sepharose
beads. Whereas the Aurora-A fragment coprecipitated
with GST-Ajuba1 (containing all three LIM domains) Activation of Aurora-A by Ajuba
and GST-Ajuba3 (containing LIM-2 and LIM-3), it did Based on our immunoprecipitation and immunoblot
not associate with the 2, 4, 5, or 6 GST-Ajuba data, we speculated that phosphorylation of Aurora-A
mutants (Figure 5B). We confirmed that the full-length is induced by interaction of the kinase with Ajuba. We
recombinant proteins, GST-Ajuba and His6-tagged examined this possibility first in a cell-free system. Puri-
Aurora-A, interacted directly (Figure 5C). However, GST- fied His6-tagged Aurora-A was incubated with various
Ajuba7, which lacks the LIM-2 and LIM-3 domains, concentrations of GST-Ajuba in a kinase reaction buffer.
did not interact with Aurora-A. The interaction between The extent of phosphorylation of Aurora-A on Thr288, as
Ajuba and Aurora-A was suggested to depend on the revealed by immunoblot analysis with T288P antibodies,
conformation of the LIM domain by the observation that increased in a manner dependent on the amount of GST-
it was blocked by TPEN, a Zn2-specific chelator that Ajuba (Figure 6A). Ajuba did not induce phosphorylation
disrupts this conformation. These in vitro binding experi- of the kinase-inactive Aurora-A mutant K162M on
ments thus demonstrated that both LIM-2 and LIM-3 Thr288 (Supplemental Figure S3A). These data thus indi-
domains of Ajuba mediate the interaction with the NH2- cated that Ajuba facilitates the phosphorylation of
terminal region of Aurora-A. Aurora-A on Thr288 and that this phosphorylation is
mediated by an autocatalytic mechanism.
Given that the phosphorylation of Thr288 appears toIn Vivo Interaction between Aurora-A and Ajuba
To determine whether Ajuba is a substrate for the kinase be critical for the kinase activity of Aurora-A (Figure 5E),
we next determined whether the Ajuba-induced auto-activity of Aurora-A, we performed an in vitro kinase
assay with recombinant His6-tagged wild-type Aurora-A phosphorylation of Aurora-A increases the kinase activ-
ity of Aurora-A toward exogenous substrates. In theor a kinase-inactive mutant thereof (K162M, in which
Lys162 in the ATP binding site is replaced with Met) and absence of GST-Ajuba, His6-tagged Aurora-A exhibited
little kinase activity toward histone H3 (Figure 6B). Inwith GST-Ajuba. Ajuba underwent marked phosphoryla-
tion on incubation with wild-type Aurora-A, but not when the presence of GST-Ajuba, however, the phosphoryla-
tion of histone H3 (and of His6-tagged Aurora-A itself)incubated with the kinase-inactive mutant (Figure 5D).
Moreover, when either COOH-terminal half-truncated was greatly increased in a manner dependent on the
concentration of Aurora-A, indicating that Ajuba stimu-(pre-LIM domain) or NH2-terminal half-truncated (LIM
domain) of GST-Ajuba was used as substrates in the lates the kinase activity of Aurora-A.
To examine further whether Ajuba induces the activa-assay, phosphorylation site(s) in Ajuba appeared to re-
Cell
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Figure 5. Interaction of Ajuba with Aurora-A
(A) Deletion mutants of human Ajuba.
(B) In vitro binding assay with a recombinant Aurora-A fragment and Ajuba deletion mutants. Purified GST-Ajuba fusion proteins (400 nM) or
GST as a control were incubated with a purified His6-tagged Aurora-A fragment (amino acids 1–129) (400 nM) and then precipitated with
glutathione-Sepharose 4B beads. Bead bound proteins were subjected to immunoblot analysis with antibodies to the His6 tag (yop); the gel
was also stained with Coomassie brilliant blue (CBB) (bottom). The input of His6-Aurora-A(1–129) into the binding reaction in shown in lane 1.
(C) Requirement for LIM-2 and LIM-3 of Ajuba for binding to Aurora-A. Purified His6-tagged full-length Aurora-A was incubated with GST,
GST-Ajuba (full length) in the absence or presence of 10 M TPEN, or GST-Ajuba7, as indicated. Proteins that bound to glutathione-Sepharose
4B beads were then precipitated and subjected to immunoblot analysis with antibodies to the His6 tag or to GST. The input of His6-Aurora-
A (full length) into the binding reaction is shown in lane 1.
(D) Phosphorylation of Ajuba by Aurora-A in vitro. Purified GST-Ajuba was incubated for the indicated times with purified His6-tagged wild-
type Aurora-A or the kinase-inactive mutant K162M in the presence of [-32P]ATP. The kinase reaction mixtures were then analyzed by SDS-
PAGE and autoradiography (top and middle); the gel was also stained with Coomassie brilliant blue (bottom).
(E) Aurora-A interacts with phosphorylated form of Ajuba. Lysates of cells expressing both HA-tagged Ajuba and either Flag-tagged wild-type
(WT) Aurora-A or kinase-inactive mutants thereof (K162M or T288A) were subjected to immunoblot analysis with antibodies to Flag or to HA
(lanes 1–4). The same cell lysates were also subjected to immunoprecipitation with antibodies to Flag, and the resulting precipitates were
subjected to immunoblot analysis with antibodies to HA or to Flag, as indicated (lanes 5–8). The lower-mobility form of HA-tagged Ajuba was
converted to the higher-mobility form by phosphatase treatment (data not shown).
(F) Interaction of endogenous Ajuba and Aurora-A in mitotic HeLa cells. Mitotic cell lysates were subjected to immunoprecipitation with
preimmune rabbit serum or rabbit antiserum to Ajuba, and the resulting precipitates (as well as cell lysate) were subjected to immunoblot
analysis with antibodies to Aurora-A or to Ajuba. Asterisk indicates rabbit immunoglobulin.
tion of Aurora-A in cells, we subjected COS-7 cells to Aurora-A resulted in the appearance of the lower-mobil-
ity (phosphorylated) forms of both proteins in a mannertransient transfection with an expression vector for Flag-
tagged Aurora-A in the presence of various amounts dependent on the abundance of Myc-Ajuba (Figure 6C).
This effect correlated with the kinase activity of Flag-of a vector for Myc epitope-tagged Ajuba. Immunoblot
analysis revealed that coexpression of Ajuba with Aurora-A immunoprecipitates toward histone H3 (Fig-
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Figure 6. Ajuba-Induced Autophosphorylation and Activation of Aurora-A
(A) Ajuba-induced autophosphorylation of Aurora-A on Thr288 in vitro. Recombinant His6-tagged Aurora-A (25 nM) was incubated with the
indicated concentrations of GST-Ajuba for 30 min at 30C in a kinase reaction buffer containing 20M ATP. The extent of Aurora-A phosphoryla-
tion was then determined by immunoblot analysis with T288P antibodies; the same blot was also probed with antibodies to the His6-tag and
to GST.
(B) Activation of Aurora-A by Ajuba in vitro. His6-Aurora-A at the indicated concentrations was incubated for 30 min at 30C in the absence
or presence of 100 nM GST-Ajuba, after which His6-Aurora-A was immunoprecipitated and incubated in kinase reaction buffer containing
histone H3 and [-32P]ATP. Phosphorylated proteins were then detected by SDS-PAGE and autoradiography. Aurora-A activity was quantitated
by densitometric scanning of the histone H3 band and expressed relative to that without Ajuba.
(C) Autoactivation of Aurora-A induced by Ajuba in cells. COS-7 cells were transfected with an expression vector for Flag-Aurora-A (wild-type
or K162M mutant) and the indicated amounts of a vector for Myc epitope-tagged Ajuba. Cell lysates were subsequently subjected to immunoblot
analysis with antibodies to the Myc or Flag epitopes (top and middle, respectively). Cell lysates were also subjected to immunoprecipitation
with antibodies to Flag, and the resulting precipitates were assayed for kinase activity with histone H3 as substrate (bottom).
(D) Aurora-A activity in experiments similar to that shown in (C) was quantitated by densitometric scanning of the histone H3 band and
expressed relative to that of cells not transfected with the Ajuba vector. Data are means 	SD of values from three independent experiments.
(E) Requirement for physical interaction for Ajuba to induce autoactivation of Aurora-A. HeLa cells were transfected with the indicated
combinations of expression vectors for Flag-Aurora-A (wild-type or K162 mutant) and Myc-Ajuba (wild-type or 7 mutant). Cell lysates were
subsequently subjected to immunoblot analysis with antibodies to Myc or to Flag or with T288P antibodies, as indicated.
ures 6C and 6D). The kinase-inactive Aurora-A mutant Ajuba-Induced Autoactivation of Aurora-A in Late
G2 Is Required for Mitotic EntryK162M was not phosphorylated when coexpressed with
Ajuba (Figure 6C), indicating that phosphorylation of We have shown that the interaction between Aurora-A
and Ajuba occurs during mitosis and that Ajuba pro-wild-type Aurora-A is mediated autocatalytically.
We examined whether the Ajuba-induced activation motes the autoactivation of Aurora-A. We therefore ex-
amined the possibility that Ajuba contributes to the acti-of Aurora-A was dependent on the ability of Ajuba to
bind to Aurora-A by coexpressing Aurora-A with the vation of Aurora-A in late G2 phase. Synchronized HeLa
cells were depleted of Ajuba by transfection with annonbinding mutant Ajuba7. Although the lower-mobil-
ity (phosphorylated) form of Ajuba was detected for Aju- Ajuba-specific siRNA (Figure 7A). Depletion of Ajuba
greatly inhibited the activation of Aurora-A without sub-ba7 as well as for the wild-type protein, Ajuba7 did not
induce the autophosphorylation of Aurora-A on Thr288 stantially affecting the abundance of this protein (Figure
7B). Immunofluorescence analysis with T288P antibod-(Figure 6E). Collectively, both our in vitro and in vivo
experiments thus demonstrated that Ajuba promotes ies revealed that whereas the proportion of nontrans-
fected cells or cells transfected with control siRNA thatthe activation of Aurora-A and that this effect results
from the physical interaction of the two proteins. exhibited intense staining of centrosomes increased
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Figure 7. Ajuba Is Essential for the Initial Activation of Aurora-A in Late G2
(A) Inhibition of Ajuba expression in synchronized HeLa cells by RNAi. Cells were transfected (or not) with Ajuba or control siRNAs during the
first thymidine-block of the cell synchronization protocol. 9 hr after the release from G1-S arrest, cells were subjected to immunoprecipitation
and immunoblot analysis with antibodies to Ajuba (top) or to immunoblot analysis with antibodies to -tubulin as a control (bottom). Arrow
indicates Ajuba, and asterisk indicates rabbit immunoglobulin.
(B) Lack of Aurora-A activation in Ajuba-depleted cells. Cells transfected with Ajuba or control siRNAs were subjected to immunoprecipitation
with antibodies to Aurora-A at the indicated times after release from G1-S arrest. The resulting precipitates were both assayed for kinase
activity with histone H3 as substrate in the presence of [-32P]ATP as well as subjected to immunoblot analysis with antibodies to Aurora-A,
as indicated.
(C) Centrosomal activation of Aurora-A requires Ajuba. Ajuba-depleted or control cells were subjected 9 hr after release to staining with Toto3
iodide (blue) as well as to immunofluorescence analysis both with T288P antibodies (FITC) (a–c) and with antibodies to cyclin B1 (Texas red)
(d–f). Scale bars, 20 m.
(D) Quantitation of the centrosomal activation of Aurora-A during G2-M progression. Synchronized Ajuba-depleted or control HeLa cells were
analyzed for centrosomal activation of Aurora-A at the indicated times after release as in (C). Approximately 200 cyclin B1-positive cells (G2
to metaphase) were scored for each sample.
(E) Aurora-A is recruited to centrosomes, but not activated, in Ajuba-depleted cells. Synchronized HeLa cells transfected with Ajuba or control
siRNAs were subjected 9 hr after release to immunofluorescence analysis with antibodies to Aurora-A (FITC) and T288P (Texas red), as
indicated. Insets represent higher-magnification images of centrosomes.
(F) Inhibition of mitotic entry in Ajuba-depleted cells. Synchronized HeLa cells transfected with control, Ajuba, or Aurora-A siRNAs were scored
for the percentage of mitotic cells at the indicated times after release from G1-S arrest. Approximately 200 cells were scored at each time
point.
markedly during progression to mitosis, only a small tions thus indicate that Ajuba is required for the activa-
tion of Aurora-A at centrosomes in late G2 phase.fraction of cells transfected with Ajuba siRNA exhibited
centrosome staining, and such staining was of low inten- To examine further the mechanism of Aurora-A activa-
tion by Ajuba, we subjected cells transfected with Ajubasity when present (Figures 7C and 7D). These observa-
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siRNA to immunofluorescence analysis both with T288P cooperate to regulate the G2-M transition during egg
maturation and that this molecular mechanism is con-antibodies and with rat antibodies that recognize both
the phosphorylated (activated) and nonphosphorylated served through evolution and is shared between mitotic
and meiotic regulation.forms of Aurora-A. Aurora-A localized to centrosomes
in the absence of Ajuba but remained in the inactive
state (Figure 7E). The demonstration that Aurora-A is Activation of Aurora-A by the Interaction
recruited to the centrosome regardless of its activation with Ajuba
status supports the notion that interaction with Ajuba One possibility for the mechanism by which Ajuba medi-
at this organelle promotes the activation of Aurora-A. ates the activation of Aurora-A is that the binding of
Having shown that the initial Aurora-A activation is Ajuba to Aurora-A induces an activating conformational
required for commitment to mitosis (Figure 2), we tested change. We noticed that GST-Aurora-A, but not His6-
whether depletion of Ajuba also inhibits mitotic entry. tagged Aurora-A, possessed marked kinase activity in
The kinetics of DNA replication were not affected by the absence of Ajuba (data not shown). It is thus conceiv-
Ajuba depletion (Supplemental Figure S4A). However, able that the NH2-terminal region of Aurora-A interacts
the ability of Ajuba-depleted cells to enter mitosis was with the catalytic domain to inhibit kinase activity and
impaired to the same marked extent as was that of that fusion of this NH2-terminal region with GST or its
Aurora-A-depleted cells (Figure 7F). Also similar to binding to Ajuba prevents this inhibitory interaction,
Aurora-A-depleted cells, Ajuba-depleted cells appeared leading to Aurora-A activation. Another possibility is that
to arrest in G2 phase, as indicated by substantial accu- Ajuba stabilizes activated Aurora-A. Phosphorylation of
mulation of cyclin B1 in the cytoplasm. The accumulated Thr288 of Aurora-A is critical not only for catalytic activa-
cyclin B1 lacked associated kinase activity toward his- tion but also for degradation of the protein (Walter et al.,
tone H1 (Supplemental Figure S4B). We conclude that 2000), suggesting that activated Aurora-A is unstable.
Ajuba plays an important role in the activation of Au- Consistent with this notion, we observed that recombi-
rora-A at centrosomes in late G2 phase and that this nant Aurora-A was more stable in the presence of Ajuba
activation is essential for cells to initiate mitosis. than in its absence (Figure 6A).
We have shown that both Aurora-A and Ajuba are
phosphorylated during their association and that theDiscussion
phosphorylation of both proteins is mediated by
Aurora-A. A nonbinding mutant of Ajuba was not able toWe have investigated the role of Aurora-A in mitotic entry
in human cells. We also identified Ajuba as a protein that induce autophosphorylation of Aurora-A. Nevertheless,
this mutant was phosphorylated by Aurora-A both inbinds to and activates Aurora-A. Our data reveal that
Ajuba is required for the activation of Aurora-A at centro- cells (Figure 6E) and in vitro, and the kinetics of the in
vitro reaction were similar for both the wild-type andsomes in late G2 phase, which is important for activation
of the cyclin B1-Cdk1 complex and commits cells to mutant Ajuba proteins (Supplemental Figures S2A and
S2B). These observations better support the possibilitymitosis. We here propose that the signaling pathway for
mitotic entry is activated in late G2 phase, before cells that the Aurora-A-Ajuba interaction is facilitated by
phosphorylation of Ajuba.are morphologically defined as M phase.
The activation of Aurora-A has also been shown to
result from downregulation of protein phosphatase 1,Ajuba As a Mitotic Regulator
which forms a complex with Aurora-A and inhibits itsWe have shown that Ajuba plays an important role in
kinase activity (Walter et al., 2000; Katayama et al.,regulation of the kinase activity of Aurora-A and that the
2001). Given that purified recombinant Aurora-A wasinteraction of Ajuba with Aurora-A is mediated by the
activated in vitro by purified recombinant Ajuba and thatnative conformation of the LIM-2 and LIM-3 domains of
this reaction was not affected by a phosphatase inhibitorAjuba. Ajuba appears to be a specific activator of
(Supplemental Figure S3B), the activation of Aurora-AAurora-A, given that it does not activate Aurora-B (Sup-
by Ajuba appears to be distinct from the phosphatase-plemental Figure S5A) and that Aurora-A is not activated
mediated regulation of this kinase.by zyxin (Supplemental Figure S5B), a protein that is
structurally related to Ajuba. We previously showed that
human WARTS, a mitotic kinase, interacts with zyxin via Requirement of Aurora-A for Mitotic Entry
in Mammalian Cellsthe LIM-1 and LIM-2 domains of the latter protein (Hirota
et al., 2000). Phosphorylation of zyxin is also required Our RNAi studies with HeLa cells have indicated that
Aurora-A and Ajuba are required for mitotic entry. Wefor its association with WARTS during mitosis. Our pres-
ent and previous observations thus indicate that LIM noticed, however, that a small population (10%) of
cells transfected with Aurora-A or Ajuba siRNAs entereddomain-containing proteins contribute to mitotic control
by interacting with mitotic kinases and that these inter- mitosis with or without a slight delay (Figures 2D and
7F); the cells that entered mitosis exhibited a variableactions require phosphorylation of the LIM proteins.
Overexpression of Eg2 (Aurora-A) in Xenopus oocytes level of T288P staining (data not shown), presumably
due to inefficient transfection, whereas the vast majorityresulted in a shortening of the time between release
from G2 arrest and entry into meiosis after progesterone of cells that remained in G2 phase were entirely negative
for T288P staining (Figure 7C). These observations sug-stimulation (Andresson and Ruderman, 1998). The effect
of overexpression of Ajuba on Xenopus egg maturation gest that a minimal activation of Aurora-A allows cells
to enter mitosis. Perturbation of Aurora-A function byis similar to that of Eg2 overexpression (Goyal et al.,
1999). It is therefore possible that Ajuba and Eg2 also injection of cells with antibodies specific for this protein
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resulted in a substantial delay (2 hr) in the initiation of actually begins. Although it remains unclear what ulti-
mately triggers the onset of Aurora-A activation, we havemitosis (Marumoto et al., 2002). Although inhibition of
mitotic entry was not complete because of the inherent demonstrated that activation of the Aurora-A-Ajuba
complex, in addition to that of the cyclin B1-Cdk1 com-limitation of antibody injection experiments, this obser-
vation also supports the notion of a requirement for only plex, is one of the earliest important molecular events
in the initiation of mitosis.minimal Aurora-A activity.
Studies in flies and worms have indicated that Au-
Experimental Proceduresrora-A controls centrosome maturation, but they did not
reveal an obvious role for this protein in mitotic entry
Two-Hybrid Screen(Glover et al., 1995; Hannak et al., 2001; Giet et al., 2002).
Two-hybrid screening was performed basically as described (Hirota
However, we have now shown that depletion of Aurora-A et al., 2000). In brief, yeast strain L40 harboring pBTM116HA-KM/
resulted in G2 delay in cultured mammalian cells. These Aurora-A(1–129) was transformed with a HeLa cDNA library in pGAD-
GH (Clontech). For efficient recovery of pGAD-GH plasmids, weapparently conflicting observations regarding the role
changed the selection marker for prokaryotes in pBTM116HA fromof Aurora-A in mitotic entry might be due to species
ampicillin resistance to kanamycin resistance.differences. Alternatively, they may be attributable to
differences in the mode of cell cycle regulation between
Antibodies
early embryonic cells and somatic cells. Early embryonic Polyclonal antibodies to human Ajuba were generated in mice and
cells, such as the syncytium in Drosophila, undergo rap- rabbits by injection with a recombinant His6-tagged NH2-terminal
idly alternating S and M phases without intervening gap fragment (amino acids 1–337) or a GST fusion protein of the COOH-
terminal portion (amino acids 271–538) of the protein, respectively.phases and without the checkpoints that are active in
The resulting rabbit antisera were subjected to affinity purificationsomatic cells.
on a column of recombinant His6-tagged Ajuba (271–538) for immu-The regulatory role of Aurora-A in centrosome matura-
nofluorescence analysis. Rabbit and rat polyclonal antibodies to
tion suggests that centrosome maturation might play Aurora-A were generated as previously described (Marumoto et al.,
an important role in the G2-M transition in mammalian 2002). The phosphoepitope-specific antibodies for Aurora-A (T288P)
cells. It is thus possible that immature centrosomes gen- and Histone H3 (Ser10) were obtained from Cell Signaling Technol-
ogy. Mouse monoclonal antibodies to Aurora-B, to cyclin B1, anderate a signal that prevents cell cycle progression.
to -tubulin (B512) were from Transduction Laboratories, and thoseDepletion of Aurora-A or Ajuba might therefore result in
to -tubulin (GTU88) and Lamin A/C were from Sigma and Santathe activation of a checkpoint pathway that monitors
Cruz, respectively. Rabbit polyclonal antibodies for pericentrin were
centrosome maturation. A second, more likely possibil- purchased from Convence. The experiment in Figure 3B was per-
ity is that cell cycle progression from late G2 phase formed with monoclonal antibody GNS1 to cyclin B1 (Santa Cruz),
through prophase is positively regulated by centro- and similar results were obtained with the monoclonal antibody from
Transduction Laboratories.somes as they mature. Centrosomes might thus provide
a site for the organization of macromolecular complexes
Recombinant Proteinsthat control the G2-M transition; the recruitment of key
For protein purification from Sf9 cells, Aurora-A cDNAs, wild-type,cell cycle regulators is important for efficient and rapid
and K162M mutant were constructed into pFastBac-HT (Gibco BRL),
mutual coactivation. This hypothesis is supported by thereby generating a baculovirus vector encoding a His6-tagged
the observation that major mitotic regulators, including Aurora-A. Optimized doses of baculoviruses were added in the
cyclin B1-Cdk1 (Figure 3; Bailly et al., 1989; Jackman growing medium 40 hr before the cell harvest. Recombinant proteins
were isolated using TALON metal-affinity resin (Clonthech). Purifiedet al., 2003), Plk1 (Lane and Nigg, 1996), as well as
His6-Aurora-A did not reveal kinase activity by itself, which wasAurora-A, accumulate at centrosomes during G2-M pro-
suitable to assess the autophorphorylation/activation of Aurora-Agression.
induced by Ajuba shown in Figure 6. For the preparation of activated
His6-Aurora-A, which was used in the in vitro kinase assays (Figure
When Does Mitosis Begin? 5), 0.1 M of okadaic acid was added to the culture medium for 2
hr, and also to the lysis buffer during the purification.Our data are consistent with the idea that Ajuba plays
an essential role in activating Aurora-A for mitotic com-
siRNA Experimentsmitment. We observed that centrosome-deposited Au-
The sequences of the siRNAs were as follows: human Aurora-A,rora-A remains inactive without Ajuba (Figure 7E). Al-
5
-AUUCUUCCCAGCGCGUUCC-3
 (corresponding to nucleotides
though the total protein amount of Ajuba does not largely 155–173 relative to the start codon) or 5
-AUGCCCUGUCUUACU
fluctuate during cell cycle, Ajuba is present on centro- GUCA-3
 (nucleotides 725–743) (Kufer et al., 2002), Aurora-B, 5
-
some specifically during G2-M phase (Figures 4D and GGUGAUGGAGAAUAGCAGU-3
 (nucleotides 168–186), Ajuba, 5
-
GGGGCGCCUAAGUGGGUUG-3
 (nucleotides 105–123), and cyclin4F). Therefore, the simplest interpretation of these data
B1, 5
-GTCAGTGAACAACTGCAGG-3
 (nucleotides 331–349). A dou-would be that recruitment of Ajuba to centrosome is
ble-stranded RNA targeting luciferase (GL-2) was used as a control.the major regulatory step for the activation of Aurora-A.
For Aurora-A siRNA analysis, the oligonucleotide targeted to posi-
However, this hypothesis does not exclude the possibil- tions 725–743 was used unless indicated otherwise. The 21 nucleo-
ity that Aurora-A and Ajuba come in contact in the cyto- tide RNA-DNA chimeric duplexes were obtained from Japan Bioser-
plasm, and then, the Aurora-A-Ajuba complex is re- vice (Asaka, Japan). Annealing of the component strands of each
siRNA and transfection were performed as described (Elbashir etcruited to the centrosome.
al., 2001).Pines and Rieder (2001) proposed the staging of mito-
sis on the basis of the status of cell cycle regulators
Immunoprecipitationthat induce morphological changes rather than on the
Mitotic cells were collected by shaking of the culture dish 9 hr after
morphological changes themselves. Our observation the release from double thymidine block. For immunoprecipitation,
that Aurora-A is activated during late G2 phase to pro- cells were lysed on ice for 30 min with NP-40 lysis buffer, consisting
of 0.5% NP-40, 20 mM Tris-HCl (pH 7.4), 500 mM NaCl, 0.5 mMmote G2-M transition provides insight into when mitosis
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